Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

471 - 480 of 3487 results found

Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised study

Date
Monday, January 29, 2024 - 4:00 AM
Description
ChulaCov19 mRNA vaccine demonstrated promising phase 1 results. Healthy adults aged 18-59 years were double-blind randomised 4:1 to receive two intramuscular doses of ChulaCov19 50 µg or placebo. Primary endpoints were safety and microneutralization